Australian study finds a protein produced by the liver can lower blood sugar lev
Recently, researchers in Australia and other countries have discovered that a protein naturally produced by the liver can lower the blood sugar levels of lab rats suffering from diabetes, and hope to develop new drugs to treat type 2 diabetes in the future. The findings have been published in the new issue of the US journal Science Translational Medicine.
Dr. Magdalene Montgomery of the University of Melbourne, Australia, who participated in the study, said the researchers found that when the blood glucose levels in the lab rats are too high, the liver will secrete a protein called secretory modular calcium-binding protein 1, from which it is assumed that this protein may be related to the control of blood glucose levels. Animal experiments show that to the diabetic rats injected after processing of this protein, the rats not only lower blood glucose levels, fatty liver control, blood cholesterol levels are also lowered.
The researchers said that the existing type 2 diabetes treatment drugs are effective, but there are tolerability and side effects and other problems, they hope that based on this protein can be developed more effective than the existing drugs, the efficacy of a new drug more durable.
The next step for the research team is to work with pharmaceutical companies to develop a new drug based on the protein that only needs to be injected once a week, and to begin clinical trials as soon as possible.
2026-10-19
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
China’s TiO₂ Industry Launches Sixth Price Hike Wave as More Than 20 Producers Follow
-
Pharma’s Tightrope in 2026: Safety, Competition and the Future of Obesity Treatment Innovation
-
Cheap Sugar, Costly Lives: WHO Pushes Governments Toward a New Era of Health Taxes
-
Singapore Orders Nestlé Formula Recall as Infant Safety Comes Under the Spotlight
-
U.S. EPA Targets Perchlorate: A New Safety Line Drawn in Drinking Water Standards
-
Celanese to Close Acetate Tow Plant in Lanaken, Belgium by 2026
-
Arkema Triples Transparent Polyamide Capacity in Singapore: a Bet on Virtual Reality Growth or a Move to Strengthen Supply Resilience?
-
Metso Expands Wear Parts Capacity in China with New Rubber Factory in Quzhou
-
New Ocean Freight GRI Takes Effect on Asia, Middle East and Africa Routes to U.S. and Canada
-
Sekisui Specialty Chemicals Has Announced a Global Price Increase
Recommend Reading
-
After 20 Years of Negotiations, 90% of Tariffs to Be Cut! EU and Mercosur Sign Free Trade Agreement: Trade Barriers Ease, Transatlantic Cooperation Warms Up?
-
Is India’s “Luck” Finally Here? HPCL’s 10-Year LNG Deal Is a High-Stakes Bet on National Destiny
-
Urea Prices Surge as India Faces Critical Shortages: Will China’s Export Quotas Provide Relief?
-
Chemours Sells Its Former Titanium Dioxide Site in Taiwan: Turning a “White Powder” Factory into “Wind Power Real Estate” for $360 Million—Buying Not Cash, But Breathing Room
-
The “Counter-Wind Ledger” of CHF 11.2 Billion: Sika Barely Grew in 2025—Yet Kept Taking Market Share
-
Falling Crude Oil Prices Weigh Down Commodities; Maleic Anhydride Market Trends Also Weaken Accordingly
-
Business Society’s Trend Analysis for Fuel Oil 180CST on September 18, 2026: Fluctuating with a Tendency to Strengthen
-
MTBE Market Trends Show Weak Fluctuations in China
-
Business Society’s Methanol Trend Analysis for September 16, 2026: Weak Rebound
-
This Week's Epichlorohydrin Market Prices Remain Stable in China (1.12-1.16)